Medicare Enrolled
Dr. Lan Luo, MD
Cardiovascular Disease · Ocala, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Luo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Luo? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Luo
Dr. Lan Luo is a cardiovascular disease in Ocala, FL, with 18 years in practice. Based on federal Medicare data, Dr. Luo performed 17,101 Medicare services across 9,503 unique beneficiaries.
Between the years covered by Open Payments, Dr. Luo received a total of $12,102 from 44 pharmaceutical and/or device companies across 531 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Luo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 2% volume in FL$ $12,102 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,101
Medicare services
Top 2% in FL for cardiovascular disease
9,503
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~950 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 5,903 | $92 | $150 |
| Echocardiogram, transthoracic | 1,234 | $127 | $305 |
| Regadenoson injection (Lexiscan) for heart stress test | 1,069 | $44 | $68 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 976 | $88 | $150 |
| Hospital follow-up visit, moderate complexity | 960 | $62 | $90 |
| Ultrasound of both sides of head and neck blood flow | 945 | $131 | $357 |
| Electrocardiogram (EKG), 12-lead | 708 | $10 | $37 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 488 | $47 | $150 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 486 | $325 | $590 |
| Remote pacemaker/defibrillator monitoring, 90 days | 457 | $16 | $44 |
| Initial hospital admission, high complexity | 445 | $134 | $275 |
| Remote pacemaker monitoring, 90 days | 361 | $21 | $45 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 359 | $82 | $210 |
| New patient office visit (45-59 min) | 301 | $117 | $215 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 298 | $26 | $50 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 235 | $19 | $35 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 193 | $39 | $70 |
| Office visit, established patient, complex (40-54 min) | 172 | $130 | $200 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 139 | $135 | $238 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 125 | $47 | $174 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 121 | $33 | $40 |
| Flu vaccine administration | 121 | $29 | $30 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 111 | $89 | $149 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 99 | $1,250 | $2,400 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 96 | $27 | $91 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 66 | $18 | $34 |
| Transitional care management services for problem of at least moderate complexity | 65 | $157 | $230 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 57 | $6 | $25 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 57 | $18 | $45 |
| Transitional care management services for problem of high complexity | 48 | $214 | $300 |
| Office visit, established patient (20-29 min) | 46 | $66 | $100 |
| Complete ultrasound study of arm and leg arteries | 44 | $93 | $275 |
| Ultrasound of leg arteries or artery grafts | 42 | $143 | $340 |
| Programming of dual lead pacemaker system | 40 | $54 | $82 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 34 | $52 | $86 |
| Hospital follow-up visit, high complexity | 33 | $94 | $131 |
| Chest X-ray, 2 views | 32 | $18 | $26 |
| Programming of multiple lead implantable defibrillator system | 26 | $72 | $126 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 21 | $15 | $36 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 21 | $10 | $36 |
| Programming of multiple lead pacemaker system | 17 | $62 | $96 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 15 | $35 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $2 | $5 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 12 | $23 | $66 |
| External shock to heart to regulate heart beat | 11 | $85 | $309 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
16.6% high complexity
20.3% medium
63.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,102
Total received (2018-2024)
Avg $1,729/year across 7 years
Top 21% in FL for cardiovascular disease
44
Companies
531
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,490 (78.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,613 (21.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,214
2023$1,389
2022$2,489
2021$1,426
2020$2,393
2019$1,266
2018$1,926
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,028
AstraZeneca Pharmaceuticals LP
$1,171
AstraZeneca UK Limited
$1,000
Amgen Inc.
$965
Janssen Pharmaceuticals, Inc
$933
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$598
Esperion Therapeutics, Inc.
$482
PFIZER INC.
$460
Regeneron Healthcare Solutions, Inc.
$426
SANOFI-AVENTIS U.S. LLC
$423
Boehringer Ingelheim Pharmaceuticals, Inc.
$360
E.R. Squibb & Sons, L.L.C.
$356
Merck Sharp & Dohme LLC
$317
Lexicon Pharmaceuticals, Inc.
$268
Abbott Laboratories
$198
Astellas Pharma US Inc
$195
Amarin Pharma Inc.
$187
Alnylam Pharmaceuticals Inc.
$178
Boston Scientific Corporation
$174
Novo Nordisk Inc
$171
Lundbeck LLC
$147
Medtronic Vascular, Inc.
$130
Philips Electronics North America Corporation
$98
Edwards Lifesciences Corporation
$95
Merck Sharp & Dohme Corporation
$79
Impulse Dynamics (USA) Inc.
$76
Kestra Medical Technology Services, Inc.
$72
Medtronic, Inc.
$58
BOSTON SCIENTIFIC CORPORATION
$53
BIOTRONIK INC.
$53
Allergan Inc.
$52
Philips North America LLC
$39
Baxter Healthcare
$38
CVRx, Inc.
$37
United Therapeutics Corporation
$32
ABIOMED
$22
Amryt Pharma Holdings Ltd
$21
Cleerly, Inc.
$20
Braemar Manufacturing, LLC
$17
CashFlow Solutions, LLC
$17
Bard Peripheral Vascular, Inc.
$15
ARALEZ PHARMACEUTICALS US INC.
$15
Biocompatibles, Inc.
$14
Kowa Pharmaceuticals America, Inc.
$14
Top 3 companies account for 34.7% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (5091) Amb Mon & Diag Und · (7999) SRC Undivided · (CM9) Amb Mon & Diag Und · AVEIR · Assure WCD · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · Cardiac Monitoring Suite · Cleerly Labs · ClosureFast · Corlanor · ELIQUIS · ENTRESTO · EVKEEZA · FARXIGA · GENERAL - VASCULAR INTERVENTION · HeartMate · HeartMate 3 Left Ventricular Assist Device · Hillrom - Cardiac Ambulatory Monitor · INGEVITY · Impella · Inpefa · JARDIANCE · JOT DX · JUXTAPID · LEQVIO · LEXISCAN · LINQ II · LOKELMA · LUX DX · LifeVest · Livalo · Lympha Press Optimal Plus(US) BT · MITRACLIP · MULTAQ · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · OPTIMIZER · Optimizer · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RESONATE · RESONATE EL ICD VR · Repatha · Reveal LINQ · SAPIEN 3 Ultra RESILIA · SQRX PULSE GENERATOR · TYVASO · VARITHENA · VENASEAL · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · Venclose Maven Catheter · Victoza · WATCHMAN · WATCHMAN FLX · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (78%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $71 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
43
Per 100K population
11.1
County median income
$58,535
Nearest hospital
ADVENTHEALTH OCALA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Luo is a clinical cardiology specialist, with above-average Medicare volume (top 2% in FL), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Luo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Luo performed 5,903 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Luo receive payments from pharmaceutical companies?
Yes. Dr. Luo received a total of $12,102 from 44 companies across 531 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Luo's costs compare to other cardiovascular diseases in Ocala?
Dr. Luo's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Luo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Ocala
Browse cardiovascular diseases in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
AstraZeneca UK Limited Payments to Doctors
See all physicians who received payments from AstraZeneca UK Limited.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology